California Doctor Convicted in Massive $45 Million Medicare Botox Fraud Scheme

A federal jury in the Central District of California convicted California physician Violetta Mailyan in what federal authorities described as one of the largest Botox-related Medicare fraud schemes uncovered in the United States, involving approximately $45 million in fraudulent billing claims tied to medically unnecessary and nonexistent treatments.

Mailyan, 45, of Glendale, owned and operated Healthy Way Medical Center, a clinic that marketed cosmetic and beauty-related services while exploiting Medicare reimbursement systems through fraudulent Botox billing tied to fabricated chronic migraine treatments.

The investigation began after the Department of Justice Health Care Fraud Section’s Data Analytics Team identified Mailyan as receiving more Medicare reimbursement payments for Botox injections than any other physician in the United States.

Evidence presented during trial showed Mailyan submitted thousands of fraudulent Medicare claims for Botox injections that were never performed, medically unnecessary, provided solely for cosmetic purposes, or unsupported by legitimate chronic migraine diagnoses and referral documentation.

Court evidence showed Mailyan billed Medicare for procedures during periods when she was traveling outside California, including trips to Cabo San Lucas, Maui, Las Vegas, Pennsylvania, and New York. Prosecutors also proved she submitted claims for injections involving a Medicare beneficiary who was incarcerated in federal prison at the time the treatments supposedly occurred.

The evidence further showed the clinic billed Medicare for thousands of injections on days when the business itself was closed, generating more than $19 million in fraudulent claims tied to impossible treatment schedules and fabricated patient encounters.

Federal prosecutors proved the operation relied heavily on falsified patient records, fabricated consent forms, altered medical documentation, and manipulated treatment histories designed to create the appearance of legitimate chronic migraine diagnoses in order to satisfy Medicare reimbursement requirements.

Trial evidence additionally showed Mailyan backdated claims to dates preceding patients’ initial contact with the clinic, creating false timelines intended to support fraudulent reimbursement submissions.

The jury also heard evidence showing Mailyan attempted to obstruct the federal investigation after investigators began examining the clinic’s billing activity. After receiving a federal grand jury subpoena for patient records, Mailyan altered medical documentation and manipulated files to falsely indicate that legitimate chronic migraine Botox treatments had been provided.

Investigators testified that the altered records were later turned over to federal authorities in an effort to conceal fraudulent activity and mislead investigators reviewing the clinic’s operations.

Federal authorities also demonstrated that proceeds from the fraud scheme were used to finance luxury purchases, high-end travel, collectible acquisitions, and substantial asset accumulation. Evidence introduced during trial included luxury vacations to Mexico and Hawaii, along with purchases such as a 17th-century crossbow valued at approximately $12,000 and artwork valued at several thousand dollars.

Following the conviction, the jury determined that multiple seized assets constituted proceeds of the fraud scheme subject to forfeiture, including a Tesla Model X, a Tesla Cybertruck, approximately $251,124 held in multiple bank accounts, brokerage accounts valued at more than $7.3 million at the time of seizure, and four California properties located in Surfside and Glendale with combined estimated equity exceeding $7.3 million.

The case reflects the expanding role of healthcare fraud analytics, reimbursement anomaly detection systems, and data-driven investigative modeling used by federal authorities to identify abnormal billing patterns across Medicare and federally funded healthcare programs.

Federal investigators increasingly rely on advanced claims analysis systems capable of detecting statistically abnormal treatment volumes, impossible procedural schedules, duplicate claims activity, geographic inconsistencies, fabricated diagnoses, and suspicious reimbursement spikes tied to healthcare providers nationwide.

Healthcare fraud enforcement remains a major federal priority due to the enormous financial burden fraudulent billing operations place on taxpayer-funded healthcare systems, insurance structures, patient care resources, and national healthcare expenditures.

Mailyan was convicted on nine counts of wire fraud and three counts of obstruction involving a criminal investigation of a healthcare offense. She is scheduled to be sentenced on September 10, 2026.

She faces up to 20 years in federal prison for each wire fraud conviction and up to five years in prison for each obstruction conviction.

The Federal Bureau of Investigation and the Department of Health and Human Services Office of Inspector General investigated the case. Trial Attorneys Sandor Callahan and Jeffrey A. Crapko prosecuted the matter for the Justice Department’s Fraud Section. Assistant U.S. Attorney Tara Vavere is handling forfeiture proceedings tied to the seized assets.

---

---

---

---

---

---

---

---

---

---

🔥 NOW AVAILABLE! 🔥

‎👉 Eclipsera – Apple Music

---

---

---

---

---